- QMRO Home
- Wolfson Institute of Preventive Medicine
- Centre for Cancer Prevention
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial
Browse
Administrators only